The rumor stems from a report claiming an unnamed 79-year-old man received access to the drug earlier this year.

Eli Lilly (LLY) stock and Novo Nordisk (NVO) stock are in focus as Medicare offers coverage for GLP-1 weight-loss drugs for ...

Wall Street’s mixed close lifts healthcare: top S&P 500 movers plus Abbott probe, 340B drug pricing shift, Medicare GLP-1 access & AZN deal—read now.

A West Virginia man is facing multiple charges after police say he sold cocaine to an undercover officer on five separate ...

Artificial intelligence is expensive to use, many companies discovered. That has led to a new era of saving costs. Credit...Andrea Chronopoulos Supported by By Eli Tan Reporting from San Francisco ...

Israel has launched its fifth competitive process to search for more natural gas in the country's ​economic waters, Energy Minister Eli Cohen said on Monday, seeking to ‌bolster domestic reserves ...

A new bipartisan nonprofit wants to help Americans who find they're out of work because of AI. It's called RAISE US and it's ...

In late June 2026, a rumor spread that U.S. President Donald Trump had gained early and exclusive access to the pharmaceutical company Eli Lilly's retatrutide — a coveted obesity drug that is ...

Millions more Americans will qualify for obesity medications at just $50 a month under a new Medicare program starting on ...

America celebrates the 250th anniversary of its independence today, with people from one end of the country to the other ...